Economy

Pacad Investment Ltd. Buys Shares of 26800 Seattle Genetics, Inc. (SGEN)

Pacad Investment Ltd. Buys Shares of 26800 Seattle Genetics, Inc. (SGEN)”

Investors are feeling more bearish on shares of the company recently if you take into consideration the increase in short interest. During the same quarter in the previous year, the company earned ($0.23) EPS. Aperio Group LLC lifted its stake in Seattle Genetics by 0.3% in the second quarter. The company's shares opened today at $53.41. About 287,760 shares traded.

In a report issued on September 12, Eun Yang from Jefferies reiterated a Buy rating on Seattle Genetics (NASDAQ: SGEN), with a price target of $53. They issued an "outperform" rating and a $58.00 target price on the stock. Matrix Capital Management Company LP now owns 2,118,000 shares of the biotechnology company's stock valued at $109,585,000 after buying an additional 335,000 shares during the last quarter. Wyndham Worldwide Corp now has $10.42B valuation.

The stock increased 0.18% or $0.05 on September 14, reaching $27.85.

About 181,581 shares traded. (NASDAQ:SGEN) has risen 75.68% since September 15, 2016 and is uptrending. It has outperformed by 26.50% the S&P500. It also reduced Tower Semiconductor Ltd (NASDAQ:TSEM) stake by 54,543 shares and now owns 43,457 shares.

Among 6 analysts covering Seattle Genetics (NDAQ:SGEN), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Seattle Genetics had 40 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has "Buy" rating by Needham on Monday, June 19. The rating was maintained by Barclays Capital on Friday, September 11 with "Overweight". BMO Capital Markets maintained the shares of DSGX in report on Tuesday, August 15 with "Hold" rating. M Partners maintained the stock with "Buy" rating in Thursday, January 14 report. Cfo4life Limited Partnership has invested 0.34% in Realty Income Corp (NYSE:O). Its up 0.10, from 1.16 in 2016Q3. 63 funds opened positions while 133 raised stakes. Tradewinds Capital Management LLC now owns 2,344 shares of the biotechnology company's stock valued at $147,000 after buying an additional 52 shares during the period. Meritage Group Inc L P, California-based fund reported 15,523 shares. Credit Suisse Ag holds 0.01% or 262,106 shares. The company has market cap of $5.36 billion. Great Lakes Advisors Ltd Com holds 0.05% or 25,067 shares. The Company's network solutions, which primarily consist of services and software, connect people to their trading partners and enable business document exchange (bookings, bills of lading, status messages); regulatory compliance and customs filing; route and resource planning, execution and monitoring; access and leverage global trade and restricted party data; inventory and asset visibility; rate and transportation management, and warehouse operations.

Since March 31, 2017, it had 0 buys, and 5 selling transactions for $3.74 million activity. $627,527 worth of Seattle Genetics, Inc. Teachers Advisors LLC increased its position in Seattle Genetics by 24.0% during the 1st quarter. It worsened, as 30 investors sold SGEN shares while 73 reduced holdings. 135.77 million shares or 1.02% less from 137.16 million shares in 2016Q3 were reported.

The analysts wrote, "Seattle Genetics and Genmab announced today that Seattle Genetics has exercised its option to co-develop the compound tisotumab vedotin, under its existing collaboration agreement with Genmab". Connecticut-based Fairfield Bush has invested 0.29% in Seattle Genetics, Inc.

Several equities research analysts have weighed in on SGEN shares. Bessemer stated it has 2,674 shares or 0% of all its holdings. Lodge Hill Capital Llc owns 443,500 shares or 4.5% of their U.S. portfolio. Bancorporation Of Mellon owns 414,024 shares for 0.01% of their portfolio. Seattle Genetics has $7500 highest and $4300 lowest target. (NASDAQ:SGEN) for 38,315 shares. Blackrock owns 0.01% invested in Seattle Genetics, Inc. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/09/16/seattle-genetics-inc-sgen-earns-hold-rating-from-cann.html. Proshare Advsrs Ltd Liability Corporation invested in 0.06% or 94,895 shares. Georgia-based Voya Investment Mngmt Limited Liability has invested 0.01% in Seattle Genetics, Inc. The biotechnology company reported ($0.39) earnings per share for the quarter, beating analysts' consensus estimates of ($0.42) by $0.03. Zacks Investment Research upgraded Seattle Genetics from a "sell" rating to a "hold" rating in a research note on Tuesday, May 2nd. (NASDAQ:SGEN). 8,304 are owned by Westpac Bk.



Like this

Latest


16 September 2017
Analysts Recommendations Express Scripts Holding Company (ESRX)
Following the sale, the vice president now directly owns 18,232 shares in the company, valued at approximately $1,120,903.36. The fund owned 3,095,131 shares of the company's stock after buying an additional 301,350 shares during the period.

16 September 2017
Top Senate Republican on tax says Big Six won't dictate tax reform
The approval process for the biggest Tax Cut & Tax Reform package in the history of our country will soon begin. He said he would love to have the Democrats working with the GOP "but we're going to do it no matter what".

16 September 2017
Live Nation Entertainment (LYV) Receiving Somewhat Favorable News Coverage, Report Finds
Alpine Woods Invsts Ltd Liability owns 17,058 shares or 0.03% of their USA portfolio. (NYSE:LYV) for 170,762 shares. (NYSE:LYV). Equities analysts expect that Live Nation Entertainment will post $0.22 EPS for the current year. (NYSE:LYV) for 1.80M shares.

16 September 2017
Friday 9/15 Insider Buying Report: AMH, AMC
A month ago, they told us to expect earnings of US$0.04 per share while three months ago their EPS consensus estimate was US$0.04. Finally, BidaskClub raised American Homes 4 Rent from a "sell" rating to a "hold" rating in a report on Saturday, August 19th.

16 September 2017
(VAR) Shares Trading down at $107.68 Varian Holds First Clinical Workshop at…
Since March 17, 2017, it had 0 buys, and 9 selling transactions for $10.10 million activity. 862 Varian Medical Systems, Inc. On Thursday, June 8 the insider LARET MARK R sold $147,761. (NYSE:VAR) to report earnings on October, 25 after the close.

16 September 2017
Diyas springs upset to reach semis in Japan
Japanese qualifier Miyu Kato breezed into the semifinals as well with a 6-1, 6-3 triumph over Serbia's Aleksandra Krunic. Kato will next face Croatia's Jana Fett, who held her nerve to see off Wang Qiang of China 6-3 4-6 6-3.

16 September 2017
Dynavax Technologies Corporation (DVAX) Getting Somewhat Favorable News Coverage, Report Finds
The biopharmaceutical company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.50) by $0.09. Earnest Partners Ltd Liability Com invested 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ: DVAX ).

16 September 2017
Discovering Momentum Stocks: PulteGroup, Inc. (PHM), Sanchez Energy Corporation (SN)
Following the transaction, the chief operating officer now owns 249,547 shares of the company's stock, valued at $5,340,305.80. BidaskClub cut shares of PulteGroup from a "strong-buy" rating to a "buy" rating in a research report on Thursday, July 13th.

16 September 2017
Venom Inc. Crossover Coming to Amazing Spider-Man, Venom
Venom , Inc . begins with an Alpha issue, continues through The Amazing Spider-Man #792-793 and Venom #159-160, and then concludes in Venom , Inc .

16 September 2017
Canadian PM concerned over Rohingya crisis
McCain has sought to remove language from a defense spending bill detailing expanded military cooperation with Myanmar.



Recommended